Free Float 64,87 %
Shares Float 486,07 M
Shares Outstanding 749,35 M
Joinn Laboratories(China)Co.,Ltd.
Share · CNE100002W27 (XSHG)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Joinn Laboratories(China)Co.,Ltd.
No Price
Closing Price XSHG 29.04.2026:
38,64 CNY
29.04.2026 07:00
Current Prices from Joinn Laboratories(China)Co.,Ltd.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 SSE |
603127.SS
|
CNY
|
29.04.2026 07:00
|
38,64 CNY
| -1,31 CNY
-3,28 %
|
Share Float & Liquidity
Invested Funds
The following funds have invested in Joinn Laboratories(China)Co.,Ltd.:
Fund | Vol. in million 20,67 | Percentage (%) 0,02 % |
Fund | Vol. in million 0,42 | Percentage (%) 0,01 % |
Fund | Vol. in million 35,35 | Percentage (%) 0,01 % |
Fund | Vol. in million 178,95 | Percentage (%) 0,01 % |
Company Profile for Joinn Laboratories(China)Co.,Ltd. Share
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.
Company Data
Name Joinn Laboratories(China)Co.,Ltd.
Company Joinn Laboratories(China)Co.,Ltd.
Website
https://www.joinn-lab.com
Primary Exchange
SSE
SSE
ISIN CNE100002W27
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Yuxia Feng
Market Capitalization 30 Mrd.
Country China
Currency CNY
Employees 2,5 T
Address A5 Rongjing East Street, 100176 Beijing
IPO Date 2017-08-25
Dividends from 'Joinn Laboratories(China)Co.,Ltd.'
| Ex-Date | Dividend per Share |
|---|---|
| 14.08.2025 | 0,03 CNY |
| 31.07.2024 | 0,16 CNY |
| 25.07.2023 | 0,56 CNY |
| 08.08.2022 | 0,50 CNY |
| 05.08.2021 | 0,35 CNY |
| 08.06.2020 | 0,34 CNY |
| 10.04.2019 | 0,30 CNY |
| 31.05.2018 | 0,30 CNY |
Stock Splits
| Date | Split |
|---|---|
| 25.07.2023 | 7:5 |
| 08.08.2022 | 7:5 |
| 05.08.2021 | 7:5 |
| 08.06.2020 | 7:5 |
| 10.04.2019 | 7:5 |
| 31.05.2018 | 7:5 |
Ticker Symbols
| Name | Symbol |
|---|---|
| SSE | 603127.SS |
More Shares
Investors who hold Joinn Laboratories(China)Co.,Ltd. also have the following shares in their portfolio:
